BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 17933859)

  • 1. Insulin resistance and endothelial cell dysfunction: studies in mammalian models.
    Kearney MT; Duncan ER; Kahn M; Wheatcroft SB
    Exp Physiol; 2008 Jan; 93(1):158-63. PubMed ID: 17933859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
    Cubbon RM; Kahn MB; Wheatcroft SB
    Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species.
    Duncan ER; Walker SJ; Ezzat VA; Wheatcroft SB; Li JM; Shah AM; Kearney MT
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1311-9. PubMed ID: 17711985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide and vascular insulin resistance.
    Wu G; Meininger CJ
    Biofactors; 2009; 35(1):21-7. PubMed ID: 19319842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.
    Channon KM
    Trends Cardiovasc Med; 2004 Nov; 14(8):323-7. PubMed ID: 15596110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR; Gokce N
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease.
    Schmidt TS; Alp NJ
    Clin Sci (Lond); 2007 Jul; 113(2):47-63. PubMed ID: 17555404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction in insulin resistance and type 2 diabetes.
    Jansson PA
    J Intern Med; 2007 Aug; 262(2):173-83. PubMed ID: 17645585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
    Rask-Madsen C; King GL
    Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):46-56. PubMed ID: 17179929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydrobiopterin and endothelial function.
    Cosentino F; Lüscher TF
    Eur Heart J; 1998 Jul; 19 Suppl G():G3-8. PubMed ID: 9717048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide.
    Newsholme P; Homem De Bittencourt PI; O' Hagan C; De Vito G; Murphy C; Krause MS
    Clin Sci (Lond); 2009 Nov; 118(5):341-9. PubMed ID: 19922417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial mechanotransduction, nitric oxide and vascular inflammation.
    Harrison DG; Widder J; Grumbach I; Chen W; Weber M; Searles C
    J Intern Med; 2006 Apr; 259(4):351-63. PubMed ID: 16594903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
    Caballero AE
    Obes Res; 2003 Nov; 11(11):1278-89. PubMed ID: 14627747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial nitric oxide synthase and calcium production in arterial geometries: an integrated fluid mechanics/cell model.
    Comerford A; Plank MJ; David T
    J Biomech Eng; 2008 Feb; 130(1):011010. PubMed ID: 18298186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
    J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Defective nitric oxide homeostasis. Common underlying mechanism between insulin resistance, sympathetic overactivity and cardiovascular morbidity and mortality].
    Schwab M; Bloch J; Duplain H; Sartori C; Scherrer U
    Medicina (B Aires); 2008; 68(3):243-50. PubMed ID: 18689158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapies targeting vascular endothelium.
    Tousoulis D; Antoniades C; Koumallos N; Marinou K; Stefanadi E; Latsios G; Stefanadis C
    Endothelium; 2006; 13(6):411-21. PubMed ID: 17169773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic linkages.
    Lteif A; Mather K
    Can J Cardiol; 2004 Aug; 20 Suppl B():66B-76B. PubMed ID: 15309208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Obesity and endothelial dysfunction].
    Taddei S; Ghiadoni L; Salvetti G; Virdis A; Salvetti A
    G Ital Cardiol (Rome); 2006 Nov; 7(11):715-23. PubMed ID: 17216913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.